EDGAR Filing Documents for 0001193125-20-249151

Form 8-K - Current report:

SEC Accession No. 0001193125-20-249151

Filing Date

2020-09-18

Accepted

2020-09-18 16:30:56

Documents

Period of Report

2020-09-15

Items

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d91031d8k.htm iXBRL	8-K	45630
2	EX-10.1	d91031dex101.htm	EX-10.1	72654
3	EX-10.2	d91031dex102.htm	EX-10.2	69338
4	EX-10.3	d91031dex103.htm	EX-10.3	69441
5	EX-10.4	d91031dex104.htm	EX-10.4	71983
6	EX-10.5	d91031dex105.htm	EX-10.5	73117
7	EX-99.1	d91031dex991.htm	EX-99.1	60259
	Complete submission text file	0001193125-20-249151.txt		713172

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	acet-20200915.xsd	EX-101.SCH	3073
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	acet-20200915_lab.xml	EX-101.LAB	18888
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	acet-20200915_pre.xml	EX-101.PRE	11862
11	EXTRACTED XBRL INSTANCE DOCUMENT	d91031d8k_htm.xml	XML	3468

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116

Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333

Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)